AWS
TEVA icon

Aris Wealth Services’s Teva Pharmaceuticals TEVA Stock Holding History

Aris Wealth Services’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		$3K Sell
51
-77
-60% -$4.99K 0.01% 312
2015
Q2 		$8K Buy
128
+83
+184% +$5.12K 0.01% 394
2015
Q1 		$3K Buy
+45
New +$2.62K ﹤0.01% 446

Other funds holding TEVA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Aris Wealth Services's TEVA Position: Q3 2015 in Review

Aris Wealth Services reduced its Teva Pharmaceuticals (TEVA) stake by 60% in Q3 2015, selling an estimated $4.99K and leaving 51 shares worth $3K. The position accounts for 0.01% of the portfolio, ranked #312.

Aris Wealth Services first reported a position in TEVA in Q1 2015 and has held it in 3 quarters since. The position peaked at $8K in Q2 2015. 823 funds tracked by Wall St. Rank hold TEVA as of Q3 2015.

  • Aris Wealth Services held 51 shares of Teva Pharmaceuticals worth $3K as of Q3 2015.
  • Aris Wealth Services sold 77 Teva Pharmaceuticals shares in Q3 2015, an estimated $4.99K.
  • Teva Pharmaceuticals made up 0.01% of Aris Wealth Services's portfolio in Q3 2015, its #312 holding.
  • Aris Wealth Services first reported a position in Teva Pharmaceuticals in Q1 2015 and has held it in 3 quarters since.
  • Aris Wealth Services's Teva Pharmaceuticals position peaked at $8K in Q2 2015.
  • 823 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2015.

Based on Aris Wealth Services's 13F filing for Q3 2015, filed 10 Nov 2015.